Personalized Prescribing Inc.

Personalized Prescribing Inc. is a company that specializes in providing a pharmacogenetic testing service for anxiety and depression, addressing critical mental health-related conditions. Their approach stands out as it integrates genetic data from brain receptors and metabolic genes to offer the most accurate drug recommendation. This innovative service has garnered favor from insurance companies and disability managers across Canada, demonstrating its acceptance and effectiveness in the market. The company, founded in 2013, operates in the Health Care and Health and Wellness industries, positioning itself at the intersection of cutting-edge technology and mental health, a progressively vital sector. However, information regarding its headquarters, last investment, and investors isn't currently available to the public. Personalized Prescribing Inc.'s innovative approach to pharmacogenetic testing for mental health conditions reflects the growing focus on personalized medicine and the potential for groundbreaking advancements in this field. The company's commitment to effectively addressing mental health challenges through genetics presents a compelling opportunity for venture capitalists seeking to support transformative healthcare solutions.